ESGCT – 2022 – Poster Presentation P150
Publications
October 11, 2022
Efficient Knockout of Both CD33 and CLL-1 by Multiplex Genome Editing of Human Hematopoietic Stem Cells Enhances the Potential of Next- Generation Transplants for Acute Myeloid Leukemia (AML) Treatment
Platform
Presented by: Juliana Xavier Ferrucio, PhD – Preclinical and Translational Biology – Vor Bio